Results 241 to 250 of about 340,047 (304)

Evaluation of the Association of Senile Macular Degeneration in Patients with Glaucoma. [PDF]

Beyoglu Eye J
Demir U, Gunturkun PN, Bozgul P.
europepmc   +1 more source

Reply to “Aflibercept 8 mg: From Ocular Clearance to Pharmacodynamic Duration”

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 11, November 2026.
Sébastien Bihorel, Joannellyn Chiu, Jason Chittenden, Thomas Eissing, Kenneth C. Turner, Joachim Höchel, Zhongqing Will He, John D. Davis, Lutz O. Harnisch   +8 more
wiley   +1 more source

Nonexudative Macular Neovascularization in Age-Related Macular Degeneration.

JAMA Ophthalmol
Thottarath S, Gurudas S, Kubravi S, Kazantzis D, Keskin AM, Sivaprasad S, EYENEON Study Group.   +6 more
europepmc   +1 more source

Glucagon-Like Peptide 1 Receptor Agonists and Age-Related Macular Degeneration Incidence. [PDF]

Ophthalmol Retina
Hallaj S, Nishida T, Kamalipour A, Longhurst CA, Freeman WR, Baxter SL, Boussina A.   +6 more
europepmc   +1 more source

Fas Ligand enhances vessel maturation and inhibits vascular leakage associated with age-related macular degeneration. [PDF]

Front Immunol
Koirala A, Marshak-Rothstein A, Ksander BR, Gregory-Ksander M.   +3 more
europepmc   +1 more source

Clinical characteristics and microperimetry of patients with myopic maculopathy referred to vision rehabilitation compared to age related macular degeneration. [PDF]

PLoS One
Lo C, Jackson ML.
europepmc   +1 more source

Early high‐dose aflibercept 8 mg clinical outcomes in wet age‐related macular degeneration patients resistant to aflibercept 2 mg or faricimab

Acta Ophthalmologica, Volume 104, Issue 7, Page e885-e887, November 2026.
Pinja Sutinen, Idan Hecht, Raimo Tuuminen   +2 more
wiley   +1 more source